dipropylacetamide has been researched along with Abnormalities, Drug-Induced in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bialer, M; Finnell, RH; Shimshoni, JA; Wlodarczyk, B; Yagen, B | 1 |
Bialer, M; Finnell, RH; Pessah, N; Wlodarczyk, B; Yagen, B | 1 |
Aoki, Y; Bialer, M; Fujiwara, M; Kurihara, H; Okada, A | 1 |
Aoki, Y; Bialer, M; Fujiwara, M; Kurihara, H; Kushima, K; Okada, A | 1 |
Aoki, Y; Bialer, M; Fujiwara, M; Kushima, K; Okada, A | 1 |
Bialer, M; Ehlers, K; Nau, H; Radatz, M; Yagen, B | 1 |
Kerr, BM; Levy, RH | 1 |
Bertilsson, L; Pacifici, GM; Rane, A; Tomson, T | 1 |
8 other study(ies) available for dipropylacetamide and Abnormalities, Drug-Induced
Article | Year |
---|---|
Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Epilepsy, Complex Partial; Mice; Rats; Stereoisomerism; Structure-Activity Relationship; Urea; Valproic Acid | 2007 |
Alpha-fluoro-2,2,3,3-tetramethylcyclopropanecarboxamide, a novel potent anticonvulsant derivative of a cyclic analogue of valproic acid.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Cyclopropanes; Epilepsy; Male; Mice; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Valproic Acid | 2009 |
Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Bone and Bones; Cartilage; Cesarean Section; Female; Fetus; Male; Mice; Molecular Structure; Neural Tube Defects; Valproic Acid | 2004 |
Polycomb homologs are involved in teratogenicity of valproic acid in mice.
Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Bone and Bones; DNA-Binding Proteins; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Gene Silencing; Histone-Lysine N-Methyltransferase; Injections, Subcutaneous; Male; Mice; Myeloid-Lymphoid Leukemia Protein; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Pregnancy; Proto-Oncogenes; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Valproic Acid; Zinc Fingers | 2004 |
Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
Topics: Abnormalities, Drug-Induced; Amides; Animals; Embryo, Mammalian; Female; Gene Expression; Gene Expression Profiling; Immediate-Early Proteins; Mice; Neural Tube Defects; Oligonucleotide Array Sequence Analysis; Pregnancy; Valproic Acid | 2005 |
Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
Topics: Abnormalities, Drug-Induced; Amides; Animals; Anticonvulsants; Body Weight; Embryo, Mammalian; Female; Fetal Death; Mice; Mice, Inbred Strains; Pentanoic Acids; Pregnancy; Teratogens; Valproic Acid | 1998 |
Inhibition of epoxide hydrolase by anticonvulsants and risk of teratogenicity.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Drug Interactions; Epoxide Hydrolases; Female; Humans; Infant, Newborn; Microsomes, Liver; Pregnancy; Valproic Acid | 1989 |
Valpromide/carbamazepine and risk of teratogenicity.
Topics: Abnormalities, Drug-Induced; Animals; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant, Newborn; Macaca mulatta; Pregnancy; Valproic Acid | 1985 |